Table 3 Duration of omalizumab therapy with total IgE and sIgE before and after treatment
From: Omalizumab in children with severe allergic disease: a case series
Patient | Duration of treatment (weeks) | Total Serum IgE (IU/L) | Serum IgEs (KU/L) | ||
|---|---|---|---|---|---|
Before treatment | After treatment | Before treatment | After treatment | ||
1 | 78 | 1003 | 490 | DP = 100 DF = 82 Olive = 68 Milk = 2.14 | DP = 59.3 DF = 36.3 Olive = 1.41 |
2 | 96 | 372 | 760 | DP = 100 DF = 100 Pellitory = 12 | DP = 100 DF = 100 Pellitory = 3.85 |
3 | 16 | 668 | 309 | Milk > 100 Bos d 8 = 100 Bos d 4 = 15.8 Bos d 5 = 9.26 | Milk > 100 Bos d 8 > 100 Bos d 4 = 20.3 Bos d 5 = 8.4 |
4 | 104 | 280 | 126 | DP = 62.8 DF = 31.3 | DP = 70 DF = 30.9 |
5 | 16 | 68.8 | 35 | Milk = 20.9 Bos d 8 = 18.1 Bos d 4 = 5.73 Bos d 5 = 3.49 | Milk = 8.93 Bos d 8 = 5.18 Bos d 4 = 4.09 Bos d 5 = 1.6 |
6 | 48 | 597 | 930 | DP = 1.18 DF = 1.12 Milk = 90 Bos d 8 = 62.3 Bos d 4 = 62.5 Bos d 5 = 36.6 | Der. P 0.25 Der. F 0.13 Milk > 100 Bos d 8 = 100 Bos d 4 > 100 Bos d 5 = 69.3 |
7 | 16 | 79.9 | 71 | Milk = 25.1 Bos d 8 = 16 Bos d 4 = 5.99 Bos d 5 = 4.24 | Milk = 9 Bos d 8 = 4.06 Bos d 4 = 2.93 Bos d 5 = 1.61 |
8 | 48 | 972 | 309 | DP = 17.1 DF = 23.4 Pellitory = 20.7 Cat = 9.51 Milk > 100 Bos d 8 > 100 Bos d 4 = 15.8 Bos d 5 = 9.26 | DP = 2.54 DF = 25.9 Pellitory = 18.1 Cat = 4.9 Milk > 100 Bos d 8 > 100 Bos d 4 = 3.87 Bos d 5 = 2.4 |